Given the complexity, increasing recognition/prevalence and suboptimal understanding of MAC lung disease, can you summarize for us the disease burden, epidemiology, risk factors, and unmet needs for this infectious condition?
Given the complexity, increasing recognition/prevalence and suboptimal understanding of MAC lung disease, can you summarize for us the disease burden, epidemiology, risk factors, and unmet needs for this infectious condition?
Presenter
Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina